PRESS RELEASE
News
-
-
-
-
-
PRESS RELEASE
Newron to present new analyses from and updates on its clinical program evaluating evenamide as an add-on treatment for schizophrenia at the 38th ECNP Congress 2025
Newron Pharmaceuticals to present new analyses and updates on evenamide as treatment for schizophrenia at the 38th ECNP Congress 2025 -
PRESS RELEASE
CBI poursuit la mise en oeuvre de sa stratégie ACE, avec un retour sur investissement de plus de 30% sur le minage de Bitcoins en septembre 2025
CBI confirme un retour sur investissement de plus de 30% grâce au minage de Bitcoins en septembre 2025 avec Blockware Solutions. Stratégie ACE renforce positionnement international -
-
PRESS RELEASE
Formycon secures U.S. License Date for proposed Aflibercept Biosimilar FYB203 following settlement and license agreement with Regeneron
Formycon secures U.S. License Date for proposed Aflibercept Biosimilar FYB203 following settlement and license agreement with Regeneron. Commercial launch expected in Q4/2026 -
-
PRESS RELEASE
CORRECTION FROM SOURCE: Early Warning News Release Regarding the Acquisition of Over 10% of the Common Shares of Alset AI Ventures Inc.
Alset AI Ventures Inc. announces acquisition of 1,807,153 common shares by Mr. Randy Gilling. The Acquiror now holds 10.82% of the company's shares. More details in the press release
